Skip to main content
OpenTrials

Clinical trial condition

Tuberous Sclerosis Complex

Explore clinical trials studying Tuberous Sclerosis Complex. Study availability and eligibility vary by location and protocol.

32 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Tuberous Sclerosis Complex trial results

Completed

Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy

NCT05323734

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +13 more
Locations
  • Arkansas Children's Research Institute Little Rock, Arkansas, United States
  • UCLA Mattel Children's Hospital, TSC Center Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • University of California, San Diego San Diego, California, United States
View all 63 locations
View Trial Details
Completed

Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC

NCT05059327

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +17 more
Locations
  • David Geffen School of Medicine at UCLA (Site #: 101) Los Angeles, California, United States
  • Kennedy Krieger Institute (Site #: 110) Baltimore, Maryland, United States
  • Boston Children's Hospital (Site #: 102) Boston, Massachusetts, United States
  • William Beaumont Hospital - Royal Oak (Site #: 104) Royal Oak, Michigan, United States
View all 27 locations
View Trial Details
Completed

Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC

NCT05495425

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +13 more
Locations
  • Fujita Health University Hospital Toyoake, Aichi-ken, Japan
  • Gunma University Hospital Maebashi, Gunma, Japan
  • Osaka University Hospital Suita, Osaka, Japan
  • Seirei Hamamatsu General Hospital Hamamatsu, Shizuoka, Japan
View Trial Details
Completed

Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex

NCT02849457

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +13 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 13 locations
View Trial Details

Related conditions